Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro

Repurposing of currently available drugs is a valuable strategy to tackle the consequences of COVID-19. Recently, several studies have investigated the effect of psychoactive drugs on SARS-CoV-2 in cell culture models as well as in clinical practice. Our aim was to expand these studies and test some...

Descripción completa

Detalles Bibliográficos
Autores principales: Fred, Senem Merve, Kuivanen, Suvi, Ugurlu, Hasan, Casarotto, Plinio Cabrera, Levanov, Lev, Saksela, Kalle, Vapalahti, Olli, Castrén, Eero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809408/
https://www.ncbi.nlm.nih.gov/pubmed/35126106
http://dx.doi.org/10.3389/fphar.2021.755600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809408/
https://www.ncbi.nlm.nih.gov/pubmed/35126106
http://dx.doi.org/10.3389/fphar.2021.755600

Ejemplares similares